http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104072348-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_127cb15e63e6ff91d582d3a77e96632c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-72 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-813 |
| filingDate | 2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb7150d61212ff17a2f306350da4baab |
| publicationDate | 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104072348-A |
| titleOfInvention | 5-(5-bromo-2-methylphenyl)-1-(4-fluorophenyl)pentane-1,4-dione and its preparation method and application |
| abstract | The invention discloses a compound of formula I 5-(5-bromo-2-methylphenyl)-1-(4-fluorophenyl)pentane-1,4-dione and its preparation method and application. Using the compound of formula I as a raw material and reacting in the presence of a sulfide reagent, the compound of formula X, an intermediate compound of anti-type II diabetes drug Canagliflozin, can be prepared. The raw materials and reagents required by the method of the invention are relatively cheap, low in cost, simple and safe in operation, good in yield, low in environmental pollution, good in economic effect, and suitable for industrial production. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110724123-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110724123-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104311532-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104311532-A |
| priorityDate | 2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.